Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Douglas G. Cole currently holds 16,000 shares of Denali Therapeutics Inc. (DNLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas G. Cole has been a net seller of DNLI stock. They have purchased $0 and sold $7.9M worth of shares.
Douglas G. Cole's most recent insider trade was on Jun 26, 2024, when they sold 16,000 shares at $5.52 per share.
Douglas G. Cole serves as Executive at Denali Therapeutics Inc. (DNLI). They have executed 78 insider transactions totaling $7.9M over their tenure at the company.
Douglas G. Cole holds the position of Executive at Denali Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Douglas G. Cole has shown a selling trading pattern, with $0 in total purchases and $7.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Douglas G. Cole was on May 13, 2011, when they sold $1.4M worth of AVEO shares. This transaction involved 76,750 shares at $17.75 per share.
Douglas G. Cole currently owns 16,000 shares of Denali Therapeutics Inc. (DNLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Douglas G. Cole's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Douglas G. Cole has 78 Form 4 filings on record as an insider at Denali Therapeutics Inc..
Set alerts for Douglas G. Cole and 40,000+ other insiders.